US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist
  • 3.8000
  • +0.0700+1.88%
Close Dec 20 16:00 ET
33.91MMarket Cap-3.49P/E (TTM)

About Marker Therapeutics Company

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

Company Profile

SymbolMRKR
Company NameMarker Therapeutics
Listing DateNov 7, 2016
Founded1991
CEODr. Juan Vera, M.D.
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address2450 Holcombe Boulevard,Suite BCM-A, MS: BCM251
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77021
Phone1-713-400-6400

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Juan Vera, M.D.
  • Director, President, Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer
  • 585.25K
  • N. David Eansor
  • Chairman of the Board
  • 124.04K
  • Steven A. Elms
  • Independent Director
  • 76.14K
  • John Wilson
  • Independent Director
  • 63.44K
  • Dr. Katharine Knobil, M.D.
  • Independent Director
  • 79.67K
Heat List
US
Overall
Symbol
Price
% Chg

No Data